In the relentless pursuit of understanding the molecular drivers behind endometrial cancer, a recent study has spotlighted XPR1 as a…

Recent research has shed light on the grave impacts of varicella, or chickenpox, particularly among immunocompromised children. This study, led…

In a groundbreaking advancement in oncology, researchers at the Abramson Cancer Center of the University of Pennsylvania have unveiled results…

Merck & Co. has completed a hat trick of phase 3 victories for its oral PCSK9 inhibitor. Navigating into the broader…

In a groundbreaking study that promises to revolutionize the field of medical diagnostics, researchers have unveiled XAIHO, a hybrid optimized…

In the realm of pediatric oncology, retinoblastoma stands as the most prevalent intraocular malignancy among children, posing significant challenges despite…

Bubble soccer, a new recreational activity combining elements of soccer and inflatable bubble suits, has rapidly gained popularity across various…

In the landscape of critical medicine, the management of sepsis remains a complex and significant challenge. As clinicians constantly seek…

Microalgae have emerged as a groundbreaking player in the arena of bioenergy production, driving a shift away from conventional biofuel…

Zymeworks is abandoning a T-cell engager after assessing the cancer drug’s benefit-risk profile in a phase 1 study. The biopharma…